EDITORIAL article
Front. Vet. Sci.
Sec. One Health
This article is part of the Research TopicOne Health Approach to Mycobacterial Infections in Veterinary ScienceView all 12 articles
Editorial: One Health Approach to Mycobacterial Infections in Veterinary Science
Provisionally accepted- 1Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, Michigan, United States
- 2Laboratorio de Micobacterias. Dto. SAMP, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, CIVETAN, CIC, CONICET, Campus Universitario, Tandil, Argentina
- 3(INPA), Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires Instituto de Investigaciones en Produccion Animal, Buenos Aires, Argentina
- 4Servicio de Micobacterias, Centro de Vigilancia Sanitaria Veterinaria (VISAVET) Universidad Complutense Madrid, Madrid, Spain
- 5CONICET Institute of Agrobiotechnology and Molecular Biology (IABIMO), Castelar, Argentina
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
2025) reviewed M. orygis, reporting its rising incidencewhich was classified as a specie in 2012, noting a marked increase in cases and emphasizing the need for advanced molecular tools to improve approaches for genomic characterizationdiversity and surveillance (Sintchencko et alSintchencko et al). They stress the need for global, harmonized monitoring systems that account for regional One Health dynamics.Accurate diagnosis is essential for identifying etiological agents. Agricultural expansion into natural ecosystems increases the risk of infections by poorly characterized mycobacteria living in natural ecosystems. mycobacterial species, highlighting the need for studies on their taxonomy and functional traits. 2025) reported mixed M. tuberculosis infection (Lineages 1 and 4) in a captive African elephant (Loxodonta africana) in South Africa, presenting pneumonia and seropositivity. These findings highlightRespiratory samples revealed Lineages (1 and 4) common in local human cases, underscoring the need for measures to prevent reversezoonotic transmission in high-burden regions (Ghielmetti et al). This case illustrates pathogen circulation between humans and wildlife in managed environments, requiring integrated veterinary-public health surveillance.Ghielmetti et al). Sintchenko et al. ( 2025) reviewed zoonotic transmission of M. orygis, identifying multiple human-animal pathways. In India, M. orygis-related TB exceeds M. bovis cases, and its rising global prevalence, particularly in Asia, spotlighthighlights its dual zoophilic and anthropophilic potential. These insights reinforce the need for cross-sector cooperation to detect emerging MTBC members capable of crossing species barriers. (Sintchenko et al).Developing effective tools for mycobacteriosis control is critical to combat tuberculosis. Currently, BCG remainsis the only licensed vaccine, yet its limitations highlightunderscore the need for improved candidates, optimized administration strategies, and compatible diagnostics. Fernández et al. (2025) evaluated heat-and phage-inactivated prototypes of M. bovis, M. caprae, and M. microti strains for protection in mice and diagnostic interference in animal's experimental modelsguinea pigs. Heat-inactivated vaccines showed greater interference with PPD-B and P22 antigens than phage-inactivated ones, though all were compatible with defined antigen-based tests. (ESAT-6, CFP-10, Rv3615c). Heat-inactivated M. microti (strain 16Z002093) exhibited the best overall performance (Fernández et al).Fernández et al.). Cuenca Lara et al. (2025) evaluated tuberculin test (TST)the potential interference of tuberculin testing in goats vaccinated with the BCG Danish strain 1331 and heat-inactivated M. bovis using intranasal and subcutaneous routes. Aapproaches. The heterologous primeboost regimen (BCG administered subcutaneously followed by intranasal heat-inactivated M. bovis) and the single-dose intranasal BCG achieved higher diagnostic specificity in TSTskin tests and Interferon Gamma Release Assays (IGRA),) compared to homologous strategies, while preserving systemic cellular responses. Further evaluationThe authors recommend further assessment under MTBC challenge conditions was recommended (Cuenca Lara et al). These strategies could improve TB control in livestock and reduce diagnostic cross-reactivity affecting trade and public health, while providing adaptable vaccination and diagnostic tools for diverse production systems.Cuenca Lara et al.).
Keywords: antimicrobial resistance, epidemiology and diagnosis, Eradication and Control, mycobacteria, One Health, Vaccine, Veterinary, zoonosis and reverse-zoonosis
Received: 31 Dec 2025; Accepted: 26 Jan 2026.
Copyright: © 2026 Marfil, Traversa, Barandiaran, Ferrara Muñiz, Zumárraga and Eirin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Maria Emilia Eirin
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
